Therefore, many researchers propose incorporating AFP and DCP into the HCC staging system, aiming to compensate for the current system’s focus only on morphological features such as tumor diameter, number, and vascular invasion (18, 19). The gene discussed is AFP; the disease is hepatocellular carcinoma.